Federal Government Announces Progress on Nation-wide Strategy for Rare Disease Drugs
Cystic Fibrosis Canada calls on the provinces and territories to implement strategy and improve access today
Read MoreNews
All media inquiries can be directed to mediarelations@cysticfibrosis.ca or by calling 1-800-378-2233.
CYSTIC FIBROSIS CANADA RELEASES CANADIAN CF REGISTRY 2021 ANNUAL DATA REPORT
Report finds nearly 25% of Canadians with CF are taking a CFTR modulator therapy
Read MoreCYSTIC FIBROSIS CANADA ASKS COMMUNITY TO GIVE HOPE FOR ALL THIS HOLIDAY SEASON
Read More
KIN CANADA’S WINNIPEG CLUB MAKES AN EXTRAORDINARY SECOND SIX-FIGURE DONATION TO CYSTIC FIBROSIS CANADA
Service club raises an extraordinary $102,640 to support cystic fibrosis research, care and advocacy
Read MoreStatement from Cystic Fibrosis Canada’s Healthcare Advisory Committee Regarding the 2022 Cold and Flu Season
Read More
ALL PROVINCES AND TERRITORIES NOW FUND TRIKAFTA FOR SIX AND UP
British Columbia becomes final jurisdiction to fund the life changing cystic fibrosis drug
Read MoreNEWFOUNDLAND AND LABRADOR EXPAND ACCESS TO TRIKAFTA, ENSURES LIFE CHANGING DRUG IS ACCESSIBLE TO THOSE WHO NEED IT
Cystic Fibrosis Canada urges British Columbia, the last jurisdiction to fund the drug for children, to fund Trikafta using CADTH’s new guidance
Read MoreTHE YUKON AND NUNAVUT EXPAND ACCESS TO TRIKAFTA, ENSURE LIFE CHANGING DRUG IS ACCESSIBLE TO THOSE WHO NEED IT
Cystic Fibrosis Canada calls on remaining provinces to fund Trikafta for children six and up and lift any overly-restrictive access criterion
Read MoreManitoba EXPANDS ACCESS TO TRIKAFTA, ENSURES LIFE CHANGING DRUG IS ACCESSIBLE TO THOSE WHO NEED IT
Cystic Fibrosis Canada calls on remaining provinces and territories to fund Trikafta for children six and up and lift any overly-restrictive access criterion.
Read MoreQUEBEC EXPANDS ACCESS TO TRIKAFTA, ENSURES LIFE CHANGING DRUG IS ACCESSIBLE TO THOSE WHO NEED IT
Cystic Fibrosis Canada calls on remaining provinces and territories to fund Trikafta for children six and up and lift any overly-restrictive access criteria.
Read More